UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer

Oncogene, 2007-10, Vol.26 (49), p.6997-7005

2007

Volltextzugriff (PDF)

Activation of AKT PKB in breast cancer predicts a worse outcome among endocrine treated patients

British journal of cancer, 2002-02, Vol.86 (4), p.540-545

2002

Volltextzugriff (PDF)

17β-hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer

British journal of cancer, 2005-02, Vol.92 (3), p.547-552

2005

Volltextzugriff (PDF)

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

British journal of cancer, 2011-05, Vol.104 (11), p.1762-1769

2011

Volltextzugriff (PDF)

Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial

British journal of cancer, 2011-03, Vol.104 (6), p.899-902

2011

Volltextzugriff (PDF)

Amplification of HSD17B1 and ERBB2 in primary breast cancer

Oncogene, 2003-01, Vol.22 (1), p.34-40

2003

Volltextzugriff (PDF)

Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols

British journal of cancer, 1995-05, Vol.71 (5), p.1013-1017

1995

Volltextzugriff (PDF)

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer

British journal of cancer, 1994-12, Vol.70 (6), p.1258-1262

1994

Volltextzugriff (PDF)

Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin

British journal of cancer, 1994-03, Vol.69 (3), p.546-549

1994

Volltextzugriff (PDF)

Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer

British journal of cancer, 2016-02, Vol.114 (3), p.248-255

2016

Volltextzugriff (PDF)

PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients

NPJ breast cancer, 2022-05, Vol.8 (1), p.61-61, Article 61

2022

Volltextzugriff (PDF)

p53 as a prognostic factor in stage I breast cancer

British journal of cancer, 1995-09, Vol.72 (3), p.715-719

1995

Volltextzugriff (PDF)

Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients

British journal of cancer, 1992-10, Vol.66 (4), p.706-711

1992

Volltextzugriff (PDF)

17 -Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer

British journal of cancer, 2005-02, Vol.92 (3), p.547-552

2005

Volltextzugriff (PDF)

17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer

British journal of cancer, 2005-02, Vol.92 (3), p.547-552

2005

Volltextzugriff (PDF)

Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer

Nature communications, 2013, Vol.4 (1), p.2175-2175, Article 2175

2013

Volltextzugriff (PDF)

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit

NPJ breast cancer, 2021-01, Vol.7 (1), p.2-2, Article 2

2021

Volltextzugriff (PDF)

Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. South East Sweden Breast Cancer Group

British journal of cancer, 1994-03, Vol.69 (3), p.546-549

1994

Volltextzugriff (PDF)

Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer

NPJ breast cancer, 2017-08, Vol.3 (1), p.28-3, Article 28

2017

Volltextzugriff (PDF)

p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group

British journal of cancer, 1995-09, Vol.72 (3), p.715-719

1995

Volltextzugriff (PDF)

Prognostic utility of HOXBI3:ILI7BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

British journal of cancer, 2011, Vol.104 (11), p.1762-1769

2011

Volltextzugriff (PDF)

Phenotype and Immunophenotype Analysis of Gene Expression Defined "Indolent Risk" Breast Cancers

LABORATORY INVESTIGATION, 2016, Vol.96, p.33A

2016

Volltextzugriff (PDF)

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

British journal of cancer, 2002-02, Vol.86 (4), p.540-545

2002

Volltextzugriff (PDF)

Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease

Scientific reports, 2022-11, Vol.12 (1), p.20519-20519, Article 20519

2022

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

KollektionNature Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(23)
Tagungsberichte
(1)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer

Activation of AKT PKB in breast cancer predicts a worse outcome among endocrine treated patients

17β-hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial

Amplification of HSD17B1 and ERBB2 in primary breast cancer

Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer

Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin

Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer

PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients

p53 as a prognostic factor in stage I breast cancer

Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients

17 -Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer

17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer

Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit

Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. South East Sweden Breast Cancer Group

Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer

p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group

Prognostic utility of HOXBI3:ILI7BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

Phenotype and Immunophenotype Analysis of Gene Expression Defined "Indolent Risk" Breast Cancers

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease

Aktive Filter

Suchergebnisse filtern